Exercise for Advanced Prostate Cancer: a Multicomponent Feasibility Trial

NACompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

February 19, 2019

Primary Completion Date

August 31, 2022

Study Completion Date

August 31, 2022

Conditions
Prostate Cancer MetastaticCastration-resistant Prostate Cancer
Interventions
OTHER

Exercise

Exercise programs will be individually tailored to the capabilities of each participant and gradually progressed accordingly. Each patient will be assigned a moderate intensity walking and strengthening program to complete at home. At baseline, 12 and 24 weeks patients will wear an accelerometer to determine activity levels. At these time points, patients will also complete a physical fitness assessment (timed sit-to-stand and six minute walking tests) and a range of quality of life questionnaires. At baseline, patients will receive a behaviour change consultation and continued support throughout the intervention. Each patient will receive a pedometer during the home-based, unsupervised regime to monitor step count and they are expected to complete a daily physical activity diary. Upon completion of the 24 week follow-up, patients will be invited to partake in semi-structured interviews to determine the effectiveness of the program and their experience throughout.

Trial Locations (1)

BT9 7JL

Northern Ireland Cancer Centre, Belfast City Hospital, Belfast

All Listed Sponsors
collaborator

HSC Public Health Agency

UNKNOWN

lead

Queen's University, Belfast

OTHER

NCT03658486 - Exercise for Advanced Prostate Cancer: a Multicomponent Feasibility Trial | Biotech Hunter | Biotech Hunter